论文部分内容阅读
目的探讨参麦注射液联用环磷酸腺苷葡甲胺注射液治疗慢性心力衰竭的疗效。方法以2005~2008年住院的慢性心力衰竭患者99例,随机分为治疗组50例和对照组49例,治疗组除常规治疗外,采用参麦、环磷酸腺苷葡甲胺注射液静脉滴注,对照组按常规剂量给予西地兰或地高辛治疗。结果两组疗效比较,差异有统计学意义(P<0.05),治疗组平均住院天数明显少于对照组(P<0.05)。结论参麦注射液联用环磷酸腺苷葡甲胺治疗慢性心力衰竭具有较好效果,值得推广应用。
Objective To investigate the curative effect of Shenmai injection combined with cyclic adenosine monophosphate meglumine hydrochloride in patients with chronic heart failure. Methods 99 patients with chronic heart failure admitted to hospital from 2005 to 2008 were randomly divided into treatment group (n = 50) and control group (n = 49). The treatment group was treated with intravenous infusion of Shenmai, cAMP Note, the control group given conventional dose of cedilanidin or digoxin treatment. Results The curative effect of the two groups was statistically significant (P <0.05), and the average length of stay in the treatment group was significantly less than that of the control group (P <0.05). Conclusion Shenmai injection combined with cyclic adenosine monophosphate meglumine treatment of chronic heart failure has good results, it is worth promoting the application.